Business Segments NovoCure Limited
Equities
NVCR
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.84 USD | +0.54% |
|
-7.26% | +6.65% |
| Jan. 14 | NovoCure Limited Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:45 AM | |
| Jan. 12 | NovoCure Reports Rise in Q4 Preliminary Revenue | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Tumor Treating Fields (TTFields) | 494M | 535M | 538M | 509M | 605M | |||||
Total Assets | 1.05B | 1.14B | 1.19B | 1.15B | 1.24B | |||||
Interest Expense | -17.66M | -3.44M | -3.33M | -3.32M | -10.34M | |||||
Income Tax Expense | -1.71M | 6.28M | 10.69M | 15.3M | 37.46M | |||||
CAPEX | -14.97M | -24.17M | -21.36M | -27.09M | -42.86M | |||||
EBT | 18.1M | -52.08M | -81.85M | -192M | -131M | |||||
Gross Profit | 388M | 420M | 423M | 381M | 468M | |||||
D&A | 7.75M | 9.17M | 9.57M | 9.7M | 9.87M | |||||
Operating Income | 30.4M | -44.33M | -89.52M | -233M | -170M | |||||
Net Income | 19.81M | -58.35M | -92.53M | -207M | -169M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 341M | 353M | 407M | 350M | 392M | |||||
Total Assets | 11.87M | 23.26M | 30.01M | 41.63M | 55.35M | |||||
Total Assets | 4.37M | 5.3M | 7.18M | 8.32M | 8.57M | |||||
Total Assets | 2.85M | 4.08M | 5.08M | 7.73M | 21.22M | |||||
Germany | 93.26M | 93.94M | 46.12M | 60.21M | 65.26M | |||||
Total Assets | 1.08M | 1.02M | 762K | - | - | |||||
France | - | - | - | - | 55.73M | |||||
Other International Markets | - | - | - | 44.49M | 42.47M | |||||
Total Assets | 1.23M | 1.15M | 1.26M | 5.18M | 7.34M | |||||
Japan | 29.08M | 34.64M | 32.78M | 31.67M | 32.57M | |||||
Total Assets | 1.23M | 799K | 1.06M | - | - | |||||
Greater China | 12.59M | 22.76M | 21.33M | 23.22M | 17.39M | |||||
Europe, Middle East and Africa (EMEA) (Excluding Germany) | 18.65M | 30.58M | 30.71M | - | - | |||||
Europe, Israel and Japan | - | - | - | - | - |
- Stock Market
- Equities
- NVCR Stock
- Financials NovoCure Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
